Skip to main content
. 2021 Mar 19;147(7):1937–1955. doi: 10.1007/s00432-021-03597-4

Fig. 3.

Fig. 3

The prognostic value of the expression of glypicans in patients with breast cancer stratified by HER2 status and triple-negative (TNBC) status. Kaplan–Meier relapse-free survival curves are plotted based on a HER2+ for GPC1, b HER2+ for GPC4, c HER2− for GPC6 and d TNBC for GPC1. Log-rank P values and hazard ratios (HRs; 95% confidence interval in parentheses) are shown. The desired Affymetrix IDs are: 202756_s_at, 204984_at and 227059_at. Discrimination into high and low expression via using the median as a cut-off